iShares S&P Global Healthcare IXJ

… Investors seeking some international flavor for their health-care exposure should consider iShares S&P Global Health Care IXJ (0.48%), as it invests almost 39% of assets in foreign-domiciled firms. Those seeking exposure only to those firms …

… performance correlation with IXJ over that time frame. These ..... assets. And in particular, IXJ is skewed heavily toward pharmaceutical ..... Japan (4.5%). Suitability IShares S & P Global Healthcare IXJ offers investors exposure to …

… seeking some international flavor for their health-care exposure should consider iShares S & P Global Healthcare IXJ (0.48%), which has 83 names. We like that IXJ invests almost 39% of assets in foreign-domiciled behemoths like Novartis …

… seeking some international flavor for their health-care exposure should consider iShares S & P Global Healthcare IXJ (0.48%), which has 83 names. We like that IXJ invests almost 39% of its assets in foreign-domiciled behemoths like Novartis …

… Sector SPDR XLV (0.18% expense ratio), the Vanguard Health Care ETF VHT (0.19%), iShares S&P Global Health Care ETF IXJ (0.48%), and the recently launched, very inexpensive Focus Morningstar Health Care Index ETF FHC (0.19%). RXL offers …

… Investors seeking international pharmaceutical exposure should consider investing in iShares S&P Global Health Care ETF IXJ , which has a 0.48% expense ratio and invests almost 40% of its assets in foreign-domiciled firms. This ETF employs full …

… And investors seeking international pharmaceutical exposure should consider investing in iShares S&P Global Health Care ETF IXJ , which has a 0.48% expense ratio and invests more than 38% of its assets in foreign-domiciled firms. This exchange …

… exposure should consider investing in iShares S & P Global Healthcare IXJ , which has a 0.48% expense ratio ..... similarly highly correlated to that of IXJ (94% correlation) over the past five years, despite IXJ 's foreign exposure. This exchange …